Entity

Time filter

Source Type

St. Louis, MO, United States

Abrams M.N.,Numerof and Associates Inc.
Medical Device and Diagnostic Industry | Year: 2010

Physicians which provide technical input, identify unmet needs, and perhaps most critically, conduct clinical trial administration and oversight. The growing corporate challenge is to mitigate compliance risk, and to ensure that increased enforcement scrutiny, disclosure requirements, and procedural safeguards don't alienate these valuable resources. The study analyzed the characteristics of medical device clinical investigators whose study sites were judged, in FDA inspection, to be entirely compliant with applicable regulations. A structured selection framework should also ensure that compensation of selected partners is clearly related to the match between their qualifications and the requirements of the study. Using an appropriately structured framework enables companies to base professional relationships on real value. This approach provides transparency by establishing a basis for valuing and managing a business relationship, addresses COI concerns, and helps provide quality data. Source


Abrams M.N.,Numerof and Associates Inc.
Trustee : the journal for hospital governing boards | Year: 2011

As hospitals bundle services, administrators will have to take a close look at clinical costs. Resolving conflicts with physicians will require strong leadership. Source


Abrams M.N.,Numerof and Associates Inc.
Trustee : the journal for hospital governing boards | Year: 2013

Accountable care is changing how boards protect their hospitals' continued viability. Source


Abrams M.N.,Numerof and Associates Inc.
Trustee : the journal for hospital governing boards | Year: 2012

Applying market dynamics to health care would bring much-needed transparency to the industry. Source


Sackman J.E.,Numerof and Associates Inc.
Pharmaceutical Technology | Year: 2013

Southeast Asia is a growing pharmaceutical market. Much like Latin America, the countries of southeast Asia, especially the members of the Association of Southeast Asian Nations (ASEAN: Brunei, Burma, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, and Vietnam), have taken initial steps towards seeking more harmonized regulation of pharmaceutical and medical-device industries. There are still significant differences, however, in how these markets are regulated, and these countries vary widely in their stage of development. Source

Discover hidden collaborations